Posts Feed
Comments Feed

Archive for the 'Multiple Sclerosis' Category

Teva Introduces New Thinner 29-Gauge Needle For COPAXONE® Pre-Filled Syringe

Jan 3rd 2009Drug InformationMultiple Sclerosis

Teva (NASDAQ:TEVA) today announced the launch of a new, thinner, 29-gauge pre-filled syringe for its multiple sclerosis (MS) treatment, COPAXONE® (glatiramer acetate injection). A recent survey of 562 MS patients found the new thinner needle was significantly preferred by 77 percent of patients over the previous 27-gauge needle. “I used to hesitate before administering my daily injection because of slight discomfort experienced in the past,” said Stacia D.

More: continued here

No Comments »

Royal Hospital For Neuro-disability And Channel 4 Highlight Ability In Disability, England

Dec 19th 2008Drug InformationMultiple Sclerosis

Next Wednesday, 17th December, the Royal Hospital for Neuro-disability features in Channel 4’s Three Minute Wonder series. As part of the week-long strand themed Life After Coma, “Blah Blah Blah” focuses on Piotr, a remarkable resident living with Locked-in Syndrome, and shows how we have been able to restore his ability to communicate and publish three collections of poetry, despite his being over 90% paralysed.

More: continued here

No Comments »

The End Of A New Era? - Scientists In Mainz And Zürich Have Contested A Popular Hypothesis Concerning The Emergence Of Multiple Sclerosis (MS)

Dec 19th 2008Drug InformationMultiple Sclerosis

During an autoimmune disease, the endogenous defence system (the immune system) loses the ability to distinguish between “self” and “foreign”. As a consequence, the immune system directs its defence against itself, with fatal consequences. In the case of multiple sclerosis, a chronic, inflammatory autoimmune disease, the immune system attacks the protective layer encapsulating the nerve fibres: This protective layer formed by myelin works like insulation for electrical cables.

More: continued here

No Comments »

« Prev - Next »

1